INNOVATE BIOPHARMACEUTICALS, INC. | Note Agreements | Business Contracts

First Amendment to the Amended and Restated Senior Secured Convertible Note Due 2025 (Filed With SEC on January 13, 2023)

Form of Amended and Restated Senior Secured Convertible Note (Filed With SEC on November 8, 2022)

Form of Senior Secured Convertible Note (Filed With SEC on June 30, 2022)

Note issued to Atlas Sciences, LLC (Filed With SEC on January 10, 2020)

Note Purchase Agreement, dated January 10, 2020, by and between the Company and Atlas Sciences, LLC (Filed With SEC on January 10, 2020)

Note issued to Atlas Sciences, LLC (Filed With SEC on March 13, 2019)

Note Purchase Agreement, dated March 8, 2019, by and between the Company and Atlas Sciences, LLC (Filed With SEC on March 13, 2019)

Option to Purchase Senior Convertible Note, by and between the Company and Gustavia Capital Partners LLC and/or its affiliates dated as of January 7, 2019 (Filed With SEC on January 11, 2019)

INNOVATE BIOPHARMACEUTICALS, INC. (58) | Note Agreements (8)